Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapie

Simple item page
datacite.alternateIdentifier.citationFrontiers in Microbiology, Vol.15, N°, -, 2024.
datacite.alternateIdentifier.doi10.3389/fmicb.2024.1374466
datacite.alternateIdentifier.issn1664-302X
datacite.creatorElfadadny, Ahmed
datacite.creatorRagab, Rokaia F.
datacite.creatorAlHarbi, Maha
datacite.creatorBadshah, Farhad
datacite.creatorIbanez Arancibia, Eliana
datacite.creatorFarag, Ahmed
datacite.creatorHendawy, Amin Omar
datacite.creatorDe los Rios Escalante, Patricio R.
datacite.creatorAboubakr, Mohamed
datacite.creatorZakai, Shadi A.
datacite.creatorNageeb, Wedad M.
datacite.date2024
datacite.rightsAcceso Abierto
datacite.subjectPseudomonas Aeruginosa
datacite.subjectResistencia
datacite.subjectPatogenicidad
datacite.subjectVirulencia
datacite.subjectTerapia
datacite.subject.englishPseudomonas aeruginosa
datacite.subject.englishresistance
datacite.subject.englishpathogenicity
datacite.subject.englishvirulence
datacite.subject.englishtherapy
datacite.titleAntimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapie
dc.date.accessioned5/27/24 14:27
dc.date.available5/27/24 14:27
dc.description.abstractPseudomonas aeruginosa, a Gram-negative bacterium, is recognized for its adaptability and opportunistic nature. It poses a substantial challenge in clinical settings due to its complicated antibiotic resistance mechanisms, biofilm formation, and capacity for persistent infections in both animal and human hosts. Recent studies revealed a potential zoonotic transmission of P. aeruginosa between animals, the environment, and human populations which highlights awareness of this microbe. Implementation of the One Health approach, which underscores the connection between human, animal, and environmental health, we aim to offer a comprehensive perspective on the current landscape of P. aeruginosa management. This review presents innovative strategies designed to counteract P. aeruginosa infections. Traditional antibiotics, while effective in many cases, are increasingly compromised by the development of multidrug-resistant strains. Non-antibiotic avenues, such as quorum sensing inhibition, phage therapy, and nanoparticle-based treatments, are emerging as promising alternatives. However, their clinical application encounters obstacles like cost, side effects, and safety concerns. Effectively addressing P. aeruginosa infections necessitates persistent research efforts, advancements in clinical development, and a comprehension of host-pathogen interactions to deal with this resilient pathogen.
dc.formatPDF
dc.identifier.issn1664-302X
dc.identifier.urihttps://repositoriodigital.uct.cl/handle/10925/5747
dc.language.isoen
dc.publisherFrontiers Media
dc.sourceFrontiers in Microbiology
dspace.entity.typePublication
oaire.citationEdition2024
oaire.citationTitleFrontiers in Microbiology
oaire.citationVolume15
oaire.fundingReferenceMinistry of Higher Education (Egypt)
oaire.fundingReferencePrincess Nourah bint Abdulrahman University
oaire.licenseConditionObra bajo licencia Creative Commons Atribución 4.0 Internacional
oaire.licenseCondition.urihttps://creativecommons.org/licenses/by/4.0/
oaire.resourceTypeArtículo de Revisión
oaire.resourceType.enReview
uct.catalogadorjvu
uct.comunidadCiencias de la Saluden_US
uct.departamentoDepartamento de Ciencias Biológicas y Químicas
uct.facultadFacultad de Recursos Naturales
uct.indizacionScience Citation Index Expanded - SCIE
uct.indizacionSCOPUS
uct.indizacionWOS
uct.indizacionDOAJ
uct.indizacionPubMed
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Elfadadny et al. - 2024 - Frontiers in Microbi - Antimicrobial resistance.pdf
Size:
8.25 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Procesos Diagnósticos y Evaluación